Detalhe da pesquisa
1.
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression.
Nat Immunol
; 20(7): 835-851, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160797
2.
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
J Hepatol
; 80(2): 322-334, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972659
3.
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.
Breast Cancer Res
; 19(1): 93, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28810913
4.
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.
Mol Ther
; 22(7): 1310-1319, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569835
5.
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.
Cancer Discov
; 14(5): 828-845, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358339
6.
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.
Mol Cancer Ther
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641411
7.
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
Proc Natl Acad Sci U S A
; 107(35): 15449-54, 2010 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713713
8.
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.
NPJ Breast Cancer
; 9(1): 66, 2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567892
9.
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Clin Cancer Res
; 29(21): 4385-4398, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279095
10.
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
Sci Rep
; 13(1): 20223, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980453
11.
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.
Int J Cancer
; 130(4): 808-16, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21387303
12.
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations.
Sci Rep
; 12(1): 1248, 2022 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075200
13.
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
Breast Cancer Res
; 13(1): 202, 2011 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21392411
14.
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.
Oncogene
; 40(26): 4425-4439, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108622
15.
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.
Clin Cancer Res
; 27(6): 1681-1694, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414137
16.
RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638434
17.
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer.
Cancer Res
; 81(21): 5572-5581, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518211
18.
Targeting PI3Kß alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss.
Oncotarget
; 11(11): 969-981, 2020 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215185
19.
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer.
Oncotarget
; 10(49): 5011-5019, 2019 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489111
20.
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.
Clin Cancer Res
; 24(24): 6594-6610, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181387